Trial · NCT07901062
Clinical Study to Evaluate the Impact of Nutraceutical Supplements in Participants With Self-Perceived Thinning Hair
NCT07901062, Not applicable, Not yet recruiting, Unilever R&D
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Clinical Study to Evaluate the Impact of Nutraceutical Supplements in Participants With Self-Perceived Thinning Hair. Trials, record NCT07901062. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07901062
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Clinical Study to Evaluate the Impact of Nutraceutical Supplements in Participants With Self-Perceived Thinning Hair
- NCT number
- NCT07901062
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 50 participants, estimated
- Lead sponsor
- Unilever R&D
- Conditions
- Hair Thinning
- Interventions
- Nutraceuticals (Prototype)
- First posted
- 2026-10-28
- Last updated
- 2026-10-28
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Serum IL-6 concentration | 8 weeks | The change in serum IL-6 measured by immunoassay. Change from baseline will be calculated at weeks 4 and 8 |
| Secondary | Targeted gene expression | 8 weeks | Changes in punch biopsy (24 targeted gene expression) at week 8 compared to baseline, measured by quantitative reverse transcription polymerase chain reaction (RT-PCR, or targeted gene expression panel). Results are reported as fold change relative to baseline. |
| Secondary | Serum and plasma level biomarkers | 8 weeks | Change in serum and plasma levels of the following biomarkers at week 4 and 8 compared to baseline: High sensitivity C reactive protein (HsCRP); Tumor Necrosis Factor-alpha (TNF-alpha); Apolipoprotein B (ApoB); Growth Differentiation Factor 15 (GDF-15); Insulin-like Growth Factor 1 (IGF-1); Lipopolysaccharide binding protein (LBP); Beclin-1, measured by immunoassay. |
| Secondary | Scalp microbiome | 8 weeks | Changes in scalp microbiome at weeks 4 and 8 compared to baseline, from swab samples by 16S RNA gene sequencing (or shotgun metagenomics). Outcomes include changes in alpha diversity, beta diversity and relative abundance of key taxa. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07901062
GET https://conductscience.org/api/trials/v1/NCT07901062/registered